# Ranibizumab Treatment for Macular Edema Secondary to Retinal Vein Occlusion

> **NCT04062370** · PHASE4 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 100 (estimated)

## Conditions studied

- Retinal Vein Occlusion
- Treatment
- Photocoagulation Burn to Retina
- Ranibizumab

## Interventions

- **DRUG:** Ranibizumab
- **DEVICE:** laser photocoagulation

## Key facts

- **NCT ID:** NCT04062370
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-01
- **Primary completion:** 2022-08-31
- **Final completion:** 2022-08-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2019-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04062370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04062370, "Ranibizumab Treatment for Macular Edema Secondary to Retinal Vein Occlusion". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT04062370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*